Australia:EBR

Positive results from first-in-human completely leadless CRT in the US, published in The Journal of the American College of Cardiology

SUNNYVALE, Calif., Oct. 25, 2023 /PRNewswire/ -- EBR Systems, Inc. (ASX:EBR), the medical device company developing wireless cardiac pacing systems, is proud to announce that positive results from the first completely leadless cardiac resynchronization therapy (CRT) ...

2023-10-26 00:00 1819

EBR Systems nominated for MTAA Excellence in Medical Technology award

SUNNYVALE, Calif., Oct. 23, 2023 /PRNewswire/ -- EBR Systems, Inc. (ASX:EBR), the developer of the world's only wireless cardiac pacing device for heart failure, is pleased to announce it has been named as a nominee for the 2023 Medical Technology Association ofAustralia ...

2023-10-23 12:26 1809

EBR Systems' Pivotal SOLVE-CRT Trial Meets Endpoints: Excellent Interim Analysis Results Lead to Early Trial Halt for Success

Data Presented at Late-Breaking Session at Heart Rhythm Society 2023: Paves Way for Premarket Approval Application for Federal Drug Administration Approval and Commercialisation * The pivotal SOLVE-CRT study evaluated EBR Systems' WiSE® CRT System, the world's first and only wireless, inside t...

2023-05-22 21:00 2515

WiSE® Technology to Feature in Upcoming APHRS Scientific Session

SUNNYVALE, Calif., Nov. 17, 2022 /PRNewswire/ -- EBR Systems, Inc. (ASX: "EBR", "EBR Systems", or the "Company"), developer of the world's only wireless cardiac pacing system for heart failure, is pleased to announce that the Company's WiSE® technology will be featured at the 15th Asia Pacific He...

2022-11-17 15:55 2216